The expression of the miR-193, miR-122 and miR-155 profiling and evaluation the serum lipid in antimony-susceptible and resistance patients with cutaneous leishmaniasis

MLA

Farzaneh Rahvar, et al. “The Expression of the MiR-193, MiR-122 and MiR-155 Profiling and Evaluation the Serum Lipid in Antimony-Susceptible and Resistance Patients with Cutaneous Leishmaniasis.” Journal of Vector Borne Diseases, vol. 61, no. 2, June 2024, pp. 306–10. EBSCOhost, https://doi.org/10.4103/jvbd.jvbd_67_20.

APA

Farzaneh Rahvar, Fatemeh Javani Jouni, Abbas Abdollahi, Azam Samei, Masoumeh Moslemi, & Hossein Vazini. (2024). The expression of the miR-193, miR-122 and miR-155 profiling and evaluation the serum lipid in antimony-susceptible and resistance patients with cutaneous leishmaniasis. Journal of Vector Borne Diseases, 61(2), 306–310. https://doi.org/10.4103/jvbd.jvbd_67_20

Chicago

Farzaneh Rahvar, Fatemeh Javani Jouni, Abbas Abdollahi, Azam Samei, Masoumeh Moslemi, and Hossein Vazini. 2024. “The Expression of the MiR-193, MiR-122 and MiR-155 Profiling and Evaluation the Serum Lipid in Antimony-Susceptible and Resistance Patients with Cutaneous Leishmaniasis.” Journal of Vector Borne Diseases 61 (2): 306–10. doi:10.4103/jvbd.jvbd_67_20.